Arcadia Biosciences, Inc. (RKDA) NASDAQ
1.01
+0.0936(+10.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.71M |
| Enterprise Value | 2.45M |
| P/E Ratio | -0.15 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.33 |
| Price/Book Ratio | 0.48 |
| Enterprise/Revenue | 0.13 |
| Enterprise/EBITDA | -0.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.96 |
| Operating Margin | -2.01 |
Management Effectiveness
| Return On Assets | -1.75 |
| Return On Equity | -2.19 |
Income Statement
| Revenue | 4.86M |
| Revenue/Share | 3.48 |
| Gross Profit | 1.76M |
| EBITDA | -9.96M |
| Net Income | -2.34M |
| Diluted EPS | -1.71 |
Balance Sheet
| Total Cash | 3.72M |
| Total Cash/Share | 2.72 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.79 |
| Book Value Per Share | 2.11 |
Price History
| 52-Week Change | -78.78 |
| 52-Week High | 6.71 |
| 52-Week Low | 0.8 |
| Moving Average 50 Days | 1.19 |
| Moving Average 200 Days | 2.62 |
Statistics
| Average Volume | 1.02M |
| Shares Outstanding | 1.55M |
| % Held by Institutions | 25.54 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | March 01, 2023 |
